Notice of intent to issue a Sole Source Award for Laboratory Accreditation

The Center for Disease Control and Prevention (CDC), Global health Center, Division for Global

HIV & TB International Laboratory Branch intends to award a sole source firm-fixed-price

contract to the American Association for Laboratory Accreditation (A2LA) for

accreditation to ISO/IEC 17025:2017, ISO/IEC 17043:2023, and ISO/IEC 15189:2022

standards. The accrediting body must perform inspection activities pursuant to formal

recognition of ILB as an accredited laboratory for these three standards. Accreditation provides

independent validation that government laboratories are conducting their work according to

documented procedures and internationally accepted quality standards. The accrediting body will

also ensures adherence to all applicable QMML requirements. The American Association for

Laboratory Accreditation (A2LA) is the only source capable of accrediting our laboratories to

ISO 15189, 17025, 17043. No solicitation will be published for this requirement. This notice is

issued solely to determine whether there are any responsible sources capable of meeting the

Government's requirements. This notice of intent is not a request for competitive quotations;

however, all capability statements, or responses received within five (5) days of the issuance of

this notice shall be considered by the Government. A determination by the Government not to

compete this proposed contract based upon responses to this notice is solely within the discretion

of the Government. Information received will normally be considered solely for the purpose of

determining whether to conduct a competitive procurement. Any capability statement, or

response should be emailed to the Contract Specialist, Eugene Gutierrez, at zvm0@cdc.gov no

later than August 7, 2026, at 2:00 pm (EST).